The dosimetric impact of heterogeneity corrections in high-dose-rate 192Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans

Brachytherapy

Volumn 11, Issue 6, 2012, Pages 515-520

  Hyer, Daniel E ^a   Sheybani, Arshin ^a   Jacobson, Geraldine M ^a   Kim, Yusung ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

3D image guided brachytherapy; Brachytherapy; Gynecological cancer; Heterogeneity correction; High dose rate brachytherapy

Indexed keywords

IRIDIUM 192;

ARTICLE; BLADDER; CANCER RISK; CLINICAL ARTICLE; DOSE CALCULATION; DOSIMETRY; FEMALE; HISTOGRAM; HUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION DOSE DISTRIBUTION; RECTUM; SIGMOID; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; IRIDIUM RADIOISOTOPES; MIDDLE AGED; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84868115844     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2012.01.011     Document Type: Article

References (32)

1. Hanks G.E., Herring D.F., Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 1983, 51:959-967.
2. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995, 22:209-234.
3. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004, 31:633-674.
4. Rivard M.J., Butler W.M., DeWerd L.A., et al. Supplement to the 2004 update of the AAPM Task Group No. 43 Report. Med Phys 2007, 34:2187-2205.
5. Poon E., Williamson J.F., Vuong T., et al. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator. Int J Radiat Oncol Biol Phys 2008, 72:1259-1266.
6. Kwan I.S., Wilkinson D., Cutajar D., et al. The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy. Med Phys 2009, 36:224-232.
7. Wareing T., Morel J., McGhee J. Coupled electron-phonon transport methods on 3-D unstructured grids. Trans Am Nucl Soc 2000, 83.
8. Wareing T., McGhee J., Morel J., et al. Discontinuous finite element SN methods on three-dimensional unstructured grids. Nucl Sci Engr 2001, 38:256-268.
9. Lewis E.E., Miller W.F. Computational methods of neutron transport 1984, John Wiley & Sons, New York, NY.
10. Gifford K.A., Horton J.L., Wareing T.A., et al. Comparison of a finite-element multigroup discrete-ordinates code with Monte Carlo for radiotherapy calculations. Phys Med Biol 2006, 51:2253-2265.
11. Gifford K.A., Price M.J., Horton J.L., et al. Optimization of deterministic transport parameters for the calculation of the dose distribution around a high dose-rate 192Ir brachytherapy source. Med Phys 2008, 35:2279-2285.
12. Borgers C. Complexity of Monte Carlo and deterministic dose-calculation methods. Phys Med Biol 1998, 43:517-528.
13. Raffi J., Davis S., DeWerd L. Comparison of TLD measured dose, TG-43 dose, and grid-based Boltzmann solver dose from intracavitary APBI for multiple reference locations in a phantom. Med Phys 2010, 37:3392.
14. Mikell J., Klopp A., Kisling K., et al. Grid-based Boltzmann solver (GBBS) vs TG-43 for Ir-192 HDR intracavitary brachytherapy: A retrospective dosimetric study. Med Phys 2010, 37:3192.
15. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
16. Haie-Meder C., Potter R., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
17. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201-211.
18. Kim Y., Huang Y., Bayouth J.E., et al. Dosimetric consequences of the prescription Point H of ABS recommendation in the era of MRI guided brachytherapy for cervical cancer: Based on GYN GEC-ESTRO recommendations of MRI guided brachytherapy. Int J Radiat Oncol Biol Phys 2008, 72:S586-587.
19. Huang Y., Kim Y. On the impact of prescription Point A on HR-CTV in MRI-guided HDR brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2010, 78:S424.
20. ICRU-report-38 Dose and volume specification for reporting intracavitary therapy in gynecology 1985, International Commission on Radiation Units and Measurements, Bethesda, MD.
21. Viswanathan A.N., Thomadsen B. American brachytherapy society cervical cancer brachytherapy task group 2010, American Brachytherapy Society, Reston, VA. http://www.americanbrachytherapy.org.
22. Koom W.S., Sohn D.K., Kim J.Y., et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 2007, 68:1446-1454.
23. Hellebust T.P., Kirisits C., Berger D., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010, 96:153-160.
24. Kim Y., Modrick J.M., Bayouth J.E., et al. Logistics of tandem and ovoids HDR plan optimization in MRI-guided brachytherapy for cervical cancer: Comparisons of standard, graphical, and inverse optimization. Brachytherapy 2009, 8:121-122.
25. Rivard M.J., Beaulieu L., Mourtada F. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. Med Phys 2010, 37:2645-2658.
26. Venselaar J., Bidmead M., Pérez-Calatayud J., et al. A practical guide to quality control of brachytherapy equipment 2004, European Society for Therapeutic Radiology and Oncology, Brussels, Belgium.
27. Mikell J.K., Mourtada F. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver. Med Phys 2010, 37:4733-4743.
28. Zourari K., Pantelis E., Moutsatsos A., et al. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: Single sources and bounded homogeneous geometries. Med Phys 2010, 37:649-661.
29. Petrokokkinos L., Zourari K., Pantelis E., et al. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator. Med Phys 2011, 38:1981-1992.
30. Shin K.H., Kim T.H., Cho J.K., et al. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys 2006, 64:197-204.
31. Raina S., Avadhani J.S., Oh M., et al. Quantifying IOHDR brachytherapy underdosage resulting from an incomplete scatter environment. Int J Radiat Oncol Biol Phys 2005, 61:1582-1586.
32. Zwahlen D., Jezioranski J., Chan P., et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009, 74:1157-1164.